-
Product Insights
Charm Grp/ DCT Partners – Charm Ho Tram Resort & Spa: The Six Premier – Ba Ria-Vung Tau
Equip yourself with the essential tools needed to make informed and profitable decisions with our Charm Grp/ DCT Partners - Charm Ho Tram Resort & Spa: The Six Premier - Ba Ria-Vung Tau report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose...
-
Product Insights
NewBiofourmis Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biofourmis Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biofourmis Inc (Biofourmis) is a provider of advanced technology and clinical support for home care and digital therapies. The company offers Care@Home platform to deliver virtual care for patients with acute, post-acute, and chronic medical conditions; and software-based therapeutics to treat and manage patients with unmet clinical needs. Its DCT (decentralized clinical trials) solution provides telehealth, active ePRO and passive...
-
Product Insights
Net Present Value Model: IMM-1104
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model IMM-1104 Drug Details IMM-1104 (IMM-1611441) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IMM-1104
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry IMM-1104 Drug Details IMM-1104 (IMM-1611441) is under development for the treatment of solid tumor,...
-
Sector Analysis
Clinical Trials – The Movement Towards Decentralized Clinical Trials
The decentralized clinical trials (DCTs) market size was 1,291 (trials) in 2021. DCTs also known as virtual trials or direct-to-participant trials, can be defined as clinical trials that use a virtual component to assist with any aspect of the trial itself, including data analysis, data collection, enrollment, and monitoring. DCTs have less necessity in traditional research facilities and data collection structures. It uses virtual components, such as telemedicine, in-home devices, mobile healthcare, mobile technology, wearable devices, virtual home visits, direct...
-
Thematic Analysis
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update
Since the first case of COVID-19 was diagnosed in Wuhan, China, in December 2019, COVID-19 cases rose rapidly across the globe. On March 11, 2020, World Health Organization (WHO) officially declared that COVID-19 is a pandemic. Over 1,200 clinical trials worldwide have either been disrupted by COVID-19 due to suspended enrollment or delayed initiation or have been impacted by slow enrollment. Regulatory guidance has been issued for industry, investigators, and institutional review boards on conducting clinical trials during the COVID-19...
-
Thematic Analysis
Virtual Clinical Trials – Thematic Research
Virtual clinical trials, also commonly referred to as decentralized clinical trials (DCTs), use digital technologies and other processes that differ from traditional trial models to bring research closer to patient’s homes in order to increase access to trials, as well as reduce inconvenience and burden on participants by decreasing the number of physical site visits. Virtual trials are also known as remote, siteless, hybrid, or digital trials. The examples of digital technologies used in virtual trials includes eConsent, telemedicine, electronic...
-
Product Insights
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2018" provides an overview of Refractory Acute Myeloid Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Refractory Acute Myeloid Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...